These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The effect of mTOR inhibition on obstructive hydrocephalus in patients with tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA). Weidman DR; Palasamudram S; Zak M; Whitney R; McCoy B; Bouffet E; Taylor M; Shroff M; Bartels U J Neurooncol; 2020 May; 147(3):731-736. PubMed ID: 32285309 [TBL] [Abstract][Full Text] [Related]
6. Acute Management of Symptomatic Subependymal Giant Cell Astrocytoma With Everolimus. Arroyo MS; Krueger DA; Broomall E; Stevenson CB; Franz DN Pediatr Neurol; 2017 Jul; 72():81-85. PubMed ID: 28511812 [TBL] [Abstract][Full Text] [Related]
7. Stereotactic endoscopic resection and surgical management of a subependymal giant cell astrocytoma: case report. Rodgers SD; Bassani L; Weiner HL; Harter DH J Neurosurg Pediatr; 2012 Apr; 9(4):417-20. PubMed ID: 22462708 [TBL] [Abstract][Full Text] [Related]
8. A Comparison of Clinical Outcomes for Subependymal Giant Cell Astrocytomas Treated with Laser Interstitial Thermal Therapy, Open Surgical Resection, and mTOR Inhibitors. Boop S; Bonda D; Randle S; Leary S; Vitanza N; Crotty E; Novotny E; Friedman S; Ellenbogen RG; Durfy S; Goldstein H; Ojemann JG; Hauptman JS Pediatr Neurosurg; 2023; 58(3):150-159. PubMed ID: 37232001 [TBL] [Abstract][Full Text] [Related]
9. Experience using mTOR inhibitors for subependymal giant cell astrocytoma in tuberous sclerosis complex at a single facility. Tomoto K; Fujimoto A; Inenaga C; Okanishi T; Imai S; Ogai M; Fukunaga A; Nakamura H; Sato K; Obana A; Masui T; Arai Y; Enoki H BMC Neurol; 2021 Mar; 21(1):139. PubMed ID: 33784976 [TBL] [Abstract][Full Text] [Related]
10. Isolated subependymal giant cell astrocytoma (SEGA) in the absence of clinical tuberous sclerosis: two case reports and literature review. Cobourn KD; Chesney KM; Mueller K; Fayed I; Tsering D; Keating RF Childs Nerv Syst; 2024 Jan; 40(1):73-78. PubMed ID: 37658938 [TBL] [Abstract][Full Text] [Related]
11. Pathological Findings of a Subependymal Giant Cell Astrocytoma Following Treatment With Rapamycin. Cheng S; Hawkins C; Taylor MD; Bartels U Pediatr Neurol; 2015 Sep; 53(3):238-242.e1. PubMed ID: 26173783 [TBL] [Abstract][Full Text] [Related]
12. Complex Factors in Hydrocephalus Development in Tuberous Sclerosis Complex: A Case Report of Subependymal Giant Cell Astrocytoma. Nakamura H; Izumi M; Omori Y; Numoto S; Fujimoto A Cureus; 2024 Jul; 16(7):e65132. PubMed ID: 39040610 [TBL] [Abstract][Full Text] [Related]
13. EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex. Fogarasi A; De Waele L; Bartalini G; Jozwiak S; Laforgia N; Verhelst H; Petrak B; Pedespan JM; Witt O; Castellana R; Crippa S; Gislimberti G; Gyorsok Z BMC Neurol; 2016 Aug; 16():126. PubMed ID: 27502586 [TBL] [Abstract][Full Text] [Related]
14. The Effect of Everolimus on Subependymal Giant Cell Astrocytoma (SEGA) in Children with Tuberous Sclerosis Complex. Bakhtiary H; Barzegar M; Shiva S; Poorshiri B; Hajalioghli P; Herizchi Ghadim H Iran J Child Neurol; 2021; 15(4):15-25. PubMed ID: 34782838 [TBL] [Abstract][Full Text] [Related]
15. Subependymal giant cell astrocytoma in the absence of tuberous sclerosis complex: case report. Beaumont TL; Godzik J; Dahiya S; Smyth MD J Neurosurg Pediatr; 2015 Aug; 16(2):134-7. PubMed ID: 25978531 [TBL] [Abstract][Full Text] [Related]
16. Everolimus: in patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex. Curran MP Paediatr Drugs; 2012 Feb; 14(1):51-60. PubMed ID: 22136276 [TBL] [Abstract][Full Text] [Related]
17. Unique findings of subependymal giant cell astrocytoma within cortical tubers in patients with tuberous sclerosis complex: a histopathological evaluation. Katz JS; Frankel H; Ma T; Zagzag D; Liechty B; Zeev BB; Tzadok M; Devinsky O; Weiner HL; Roth J Childs Nerv Syst; 2017 Apr; 33(4):601-607. PubMed ID: 28074282 [TBL] [Abstract][Full Text] [Related]
18. Dose-level response rates of mTor inhibition in tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA). Weidman DR; Pole JD; Bouffet E; Taylor MD; Bartels U Pediatr Blood Cancer; 2015 Oct; 62(10):1754-60. PubMed ID: 25929843 [TBL] [Abstract][Full Text] [Related]
19. Subependymal giant cell astrocytoma in the absence of tuberous sclerosis: illustrative case. Shelley I; Mahtabfar A; Farrell CJ J Neurosurg Case Lessons; 2023 Jun; 5(25):. PubMed ID: 37354433 [TBL] [Abstract][Full Text] [Related]
20. Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012. Roth J; Roach ES; Bartels U; Jóźwiak S; Koenig MK; Weiner HL; Franz DN; Wang HZ Pediatr Neurol; 2013 Dec; 49(6):439-44. PubMed ID: 24138953 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]